Malignancy and Malignancy Screening in Women with Solid Organ Transplants

Thursday, December 17, 2009

Dr. Roslyn Mannon, Professor of Medicine and Surgery, and Director of Transplantation Research at the University of Alabama presents, a thorough discussion of the relevant issues in maligancy detection, diagnosis and management in patients with kidney transplants, the role of specific immunosuppression in patients with malignancies and gives guidelines for the waitlisting of patients with prior malignancies. The listener of this podcast will have up-to-date approaches to the pathophysiology of cancer as well as strategies for better detection and treatment in their kidney transplant patients.

Educational Content Disclaimer: The content, information, opinions, and viewpoints contained in educational materials housed on and linked from the AST web site are those of the authors or contributors of such materials. While the AST and its committees take great care to screen the credentials of the contributors and make every attempt to review the contents, AST MAKES NO WARRANTY, EXPRESSED OR IMPLIED, as to the completeness or accuracy of the content contained in the educational materials or on this website. The reader of these materials uses these materials at his or her own risk, and AST shall not be responsible for any errors, omissions, or inaccuracies in these materials, whether arising through negligence, oversight, or otherwise. Reliance on any information appearing on this site is strictly at your own risk. Read the full disclaimer.